By Laura Morgan
Kidney cancers are among the 10 most common cancers in men and women in the United States. According to the American Cancer Society, about 62,700 new cases of kidney cancer will be diagnosed in the United States in 2016, and 14,240 people will die from the disease.
FDA Approvals, News & UpdatesKidney CancerNewsworthy
The use of Opdivo with Yervoy is the first immunotherapy combination therapy approved by the FDA for patients with kidney cancer.
Kidney CancerPatient Stories
Richard J. Smith tells his experience with kidney cancer, which led him to lose weight, be more active, and live a healthy life.
A Guide to Kidney Cancer for Survivors and Caregivers: Empowerment Through Knowledge, Communication, and Self-Care
Carly Gerretsen, DNP, RN, FNP-C, RNFA, offers an overview of kidney cancer and the treatment options, advising how to take control of controllable factors and take care of yourself.
Carly Gerretsen, DNP, RN, FNP-C, RNFA, provides an overview of kidney cancer, explaining the various stages of a kidney cancer diagnosis, symptoms, treatment options, caregiver’s assistance, and stress management advice.
Kidney CancerFDA Approvals, News & Updates
In November 2021, the FDA approved a new indication for the immunotherapy Keytruda (pembrolizumab) for adjuvant treatment (after surgery) of patients with renal-cell carcinoma that is at intermediate-high or high risk for recurrence.
Patient StoriesKidney Cancer
By Mike Morris
By 2012, Mike Morris has completed a triathlon in all 50 states. In 2015, he hiked Mt. Kilimanjaro. Then, a CT scan showed that he had metastatic renal-cell carcinoma that spread to his brain.
Results 1 - 12 of 12